Tubal ligation

Tubal ligation
Ligadura trompa derecha.JPG
Right Fallopian tube prior to ligation
Background
Birth control type Sterilization
First use 1930
Failure rates (first year)
Perfect use 0.5%
Typical use 0.5%
Usage
Duration effect Permanent
Reversibility Sometimes
User reminders None
Clinic review None
Advantages and disadvantages
STD protection No
Risks Operative and postoperative complications.

Tubal ligation (informally known as getting one's "tubes tied") is a form of female sterilization, in which the fallopian tubes are severed and sealed or "pinched shut", in order to prevent fertilization.

Contents

Procedure

There are mainly four occlusion methods for tubal ligation, typically carried out on the isthmic portion of the fallopian tube, that is, the thin portion of the tube closest to the uterus.

Interval tubal ligation is not done after a recent delivery., in contrast to postpartum tubal ligation.

In addition, a bilateral salpingectomy is effective as a tubal ligation procedure. A tubal ligation can be performed as a secondary procedure when a laparotomy is done; i.e. a cesarean section. Any of these procedures may be referred to as having one's "tubes tied."

Tubal ligation can be performed under either general anesthesia or local anesthesia (spinal or epidural, often supplemented with a tranquilizer to calm the patient during the procedure). The default in tubal ligations following on from cesarean birth is usually spinal/epidural, while the default in non-childbirth related situations may be general anesthesia as a matter of doctor preference. However, tubal ligations under local anesthesia, either inpatient or outpatient, may be performed under patient request.

Entry to the site of tubal ligation can be done in many forms; through a vaginal approach, through laparoscopy, a minilaparotomy ("minilap"), or through regular laparotomy.

Another form of permanent birth control is the non-surgical Essure procedure that has been in use since 2002. In this procedure an Essure trained doctor inserts soft, flexible inserts through the body’s natural pathways (vagina, cervix, and uterus) and into your fallopian tubes using a hysteroscope and the Essure placement tool. The micro-inserts produce eventual occlusion of the fallopian tubes by causing the in-growth of tissue.

Effectiveness

A tubal ligation is approximately 99% effective in the first year following the procedure. In the following years the effectiveness may be reduced slightly since the fallopian tubes can, in some cases, reform or reconnect which can cause unwanted pregnancy. Method failure is difficult to detect, except by subsequent pregnancy, unlike with vasectomy or IUD. If pregnancy does occur it carries a 33% chance of being an ectopic pregnancy.

Reversal

Generally tubal ligation procedures are done with the intention to be permanent, and most patients are satisfied with their sterilizations. Tubal reversal is microsurgery to repair the fallopian tube after a tubal ligation procedure.

Usually there are two remaining fallopian tube segments—the proximal tubal segment that emerges from the uterus and the distal tubal segment that ends with the fimbria next to the ovary. The procedure that connects these separateds of the fallopian tube is called tubal reversal or microsurgical tubotubal anastomosis.

In a small percentage of cases, a tubal ligation procedure leaves only the distal portion of the fallopian tube and no proximal tubal opening into the uterus. This may occur when monopolar tubal coagulation has been applied to the isthmic segment of the fallopian tube as it emerges from the uterus. In this situation, a new opening can be created through the uterine muscle and the remaining tubal segment inserted into the uterine cavity. This microsurgical procedure is called tubal implantation, tubouterine implantation, or uterotubal implantation.

Tubal reversal, if done by a specialist microsurgeon, has a high success rate and few complications. Successful repair of the fallopian tubes is now possible in 98% of women who have had a tubal ligation, regardless of the type of sterilization procedure.

IVF in vitro fertilization may overcome fertility problems in patients not suited to a tubal reversal.

Prevalence

Worldwide, female sterilization is used by 33% of married women using contraception,[2] making it the most common contraceptive method.[3] As of June 2010, there is a recent decline of tubal ligation procedures in the United States after two decades of stable rates, possibly explained by an improved access to a wide range of highly effective reversible contraceptives.[4]

Access

In developing countries, tubal ligation is generally a popular form of birth control, and is widely available, although some Muslim countries (e.g. Egypt and Indonesia) do not permit it.[5] Faith-based medical institutions in developed countries will sometimes refuse to perform tubal ligations,[6] and where long waiting times persist, there is a worrying risk of pregnancy or complications due to alternative contraception.[7] Because of the permanent nature of the operation, women under 30 without children are often denied access to tubal ligation, even if they express a determined desire not to have children.[8]

Advantages and disadvantages

Tubal ligation is a more major surgery than vasectomy, and carries greater risks. Postoperative complications are more likely than with vasectomy, and more costly.[9] For instance, in industrialized nations, mortality is 4 per 100,000 tubal ligations, versus 0.1 per 100,000 vasectomies.[10]

Tubal ligation has a larger initial cost than other contraceptive methods. Typically vasectomies are more cost-effective than tubal ligation because they are less expensive. It may take more than a decade of use for tubal ligation to become as cost-effective as other highly effective, long term methods like IUD or implant. Continued method costs or costs from unintended pregnancies make many other methods as or more costly than tubal ligation if used for several years.[9] The cost of tubal ligation is reduced if it is performed during a cesarean section since the tubes are already exposed during the laparotomy.

Tubal ligation may reduce risk of ovarian cancer.[11][12]

In other animals

References

  1. 1.0 1.1 1.2 1.3 Female Sterilization Occlusion Techniques Sarah Keller. Network Vol. 18, No. 1, Fall 1997.
  2. (PDF) Family Planning Worldwide: 2008 Data Sheet. Population Reference Bureau. 2008. http://www.prb.org/pdf08/fpds08.pdf. Retrieved 2008-06-27.  Data from surveys 1997-2007.
  3. World Health Organization (2002). "The intrauterine device (IUD)-worth singing about". Progress in Reproductive Health Research (60): 1–8. http://www.who.int/reproductive-health/hrp/progress/60/news60.html. 
  4. Chan LM, Westhoff CL (June 2010). "Tubal sterilization trends in the United States". Fertil. Steril. 94 (1): 1–6. doi:10.1016/j.fertnstert.2010.03.029. PMID 20497790. 
  5. Campbell M, Sahin-Hodoglugil NN, Potts M (2006). "Barriers to fertility regulation: a review of the literature". Studies in family planning 37 (2): 87–98. doi:10.1111/j.1728-4465.2006.00088.x. PMID 16832983. 
  6. "Woman given settlement after being denied tubal ligation". CBC news website (CBC news). September 13, 2007. http://www.cbc.ca/canada/saskatchewan/story/2007/09/13/tubal-ligation.html. Retrieved 2007-10-18. 
  7. Penava D, Daskalopoulos R, Nisker J, Hammond JA (2006). "Lack of timely access to tubal ligation increases risks of unintended pregnancy". Women's health issues : official publication of the Jacobs Institute of Women's Health 16 (1): 1–3. doi:10.1016/j.whi.2005.08.002. PMID 16487918. 
  8. Z., Bonnie (July 19, 2007). "Tubal ligation procedures denied to young women who don’t want children". American Sexuality magazine (nsrc.sfsu.edu). http://nsrc.sfsu.edu/article/tubal_ligation_denied. Retrieved 2007-10-18. 
  9. 9.0 9.1 James Trusell, et al. (April 1995). "Economic value of contraception" (PDF). American Journal of Public Health 85 (4): 494–503. doi:10.2105/AJPH.85.4.494. PMID 7702112. PMC 1615115. http://www.ajph.org/cgi/reprint/85/4/494.pdf. 
  10. Ninaad S. Awsare, Jai Krishnan, Greg B. Boustead, Damian C. Hanbury, and Thomas A. McNicholas (2005). "Complications of vasectomy.". Ann R Coll Surg Engl 87 (6): 406–410. doi:10.1308/003588405X71054. PMID 16263006. PMC 1964127. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=16263006. 
  11. Miracle-McMahill HL, Calle EE, Kosinski AS, et al. (February 1997). "Tubal ligation and fatal ovarian cancer in a large prospective cohort study". Am. J. Epidemiol. 145 (4): 349–57. PMID 9054239. 
  12. Salvador S, Gilks B, Köbel M, Huntsman D, Rosen B, Miller D (January 2009). "The fallopian tube: primary site of most pelvic high-grade serous carcinomas". Int. J. Gynecol. Cancer 19 (1): 58–64. doi:10.1111/IGC.0b013e318199009c (inactive 2010-03-20). PMID 19258943.